(Q38357568)

2 September 2017

title

Evaluation of toll-like receptor 4 gene expression of immortalized human liver cell lines (English)

1 reference

2 September 2017

0 references

Kobayashi N

1

1 reference

2 September 2017

Takesue M

2

1 reference

2 September 2017

Kobayashi N

3

1 reference

2 September 2017

Okitsu T

4

1 reference

2 September 2017

Matsumura T

5

1 reference

2 September 2017

Totsugawa T

6

1 reference

2 September 2017

Maruyama M

7

1 reference

2 September 2017

Morimoto Y

8

1 reference

2 September 2017

Kunieda T

9

1 reference

2 September 2017

Shibata N

10

1 reference

2 September 2017

Ohmoto K

11

1 reference

2 September 2017

Yamamoto S

12

1 reference

2 September 2017

Tanaka N

13

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Transplantation Proceedings

2 September 2017

published in

1 reference

2 September 2017

volume

35

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

431-432

1 reference

Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

Prolonged maintenance of active cytochrome P-450 in adult rat hepatocytes co-cultured with another liver cell type

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

Controlled expansion of human endothelial cell populations by Cre-loxP-based reversible immortalization.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

Bacterial lipopolysaccharide induces transforming growth factor beta and hepatocyte growth factor through toll-like receptor 2 in cultured human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

Molecular basis of host-pathogen interaction in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

Staphylococcal enterotoxin B induces potent cytotoxic activity by intraepithelial lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

Innate immunity: impact on the adaptive immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

Toll, a new piece in the puzzle of innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

Classification, etiology, and considerations of outcome in acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2802%2903800-9

7 January 2021

10.1016/S0041-1345(02)03800-9

Identifiers

DOI

1 reference

2 September 2017

1 reference